Papel de la vía de señalización mediada por LIGHT en la reprogramación de las células de músculo liso vascular en la aterosclerosis.
Datos básicos
- Protocolo:
- FPU20/04916
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
- Año de incio:
- 2021
- Año de finalización:
- 2025
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
MINISTERIO EDUCACION, CULTURA Y DEPORTE
Resultados del Ensayo Clínico
LIGHT DEFICIENCY IN APOE-/- MICE AGGRAVATES ATHEROMA PLAQUE BY ENHANCING APOPTOSIS
Hurtado-Genovés, G; (...); González-Navarro, H
Meeting Abstract. 2024
Light deficiency in Apoe-/-mice increases atheroma plaque size and vulnerability by modulating local immunity.
Hurtado-Genovés, G; (...); González-Navarro, H
Article. 10.1016/j.bbadis.2024.167052. 2024
Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists.
Jimenez-Marti, Elena; (...); Gonzalez-Navarro, Herminia
Article. 10.3390/nu14183775. 2022
Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice.
Taberner-Cortés A; (...); González-Navarro H
Article. 10.1016/j.jnutbio.2024.109711. 2024
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin ? receptor and the tumor necrosis factor receptor
Martin-Vano, S; (...); Gonzalez-Navarro, H
Article. 10.1016/j.arteri.2022.05.003. 2023